Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | MMP13 | P45452 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13626251 | 0.94 | LMNA (0.62) | LMNAGAAKMT2AALDH1A1MAPT | |
| SCHEMBL13626199 | 0.92 | ALDH1A1 (0.56) | LMNAGAAKMT2AALDH1A1MAPT | |
| SCHEMBL10907507 | 0.90 | LMNA (0.61) | LMNAGAAKMT2AALDH1A1MAPT | |
| SCHEMBL12722287 | 0.89 | LMNA (0.56) | LMNAGAAKMT2AALDH1A1MAPT | |
| SCHEMBL12722233 | 0.89 | LMNA (0.56) | LMNAGAAKMT2AALDH1A1MAPT | |
| SCHEMBL18969717 | 0.87 | LMNA (0.49) | LMNAGAAKMT2AALDH1A1MAPT | |
| SCHEMBL18295376 | 0.87 | LMNA (0.49) | LMNAGAAKMT2AALDH1A1MAPT | |
| SCHEMBL645265 | 0.86 | KMT2A (0.69) | LMNAGAAKMT2AALDH1A1MAPT | |
| SCHEMBL15763957 | 0.86 | KIF11 (0.50) | LMNAGAAKMT2AALDH1A1MAPT | |
| SCHEMBL13417357 | 0.86 | KMT2A (0.53) | LMNAGAAKMT2AALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240019738-A1 | DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF | JAPAN DISPLAY INC. (JP) | 2024-01-18 | — | — | US | disclosed |
| CN-110914334-A | Polyester copolymer | 阿凡田知识中心有限公司 | 2020-03-24 | — | — | CN | disclosed |
| WO-2018160911-A1 | SUSTAINABLE, ENERGY-CURABLE POLYESTER POLYOLS AND COATINGS OR RIGID FOAMS THEREFROM | RESINATE MATERIALS GROUP, INC. (US) | 2018-09-07 | — | — | WO | disclosed |
| US-10011772-B2 | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-07-03 | — | — | US | disclosed |
| US-9976086-B2 | Liquid crystal aligning agent containing polyimide precursor having thermally-leaving group and/or polyimide | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-05-22 | — | — | US | disclosed |
| US-20160264867-A1 | LIQUID CRYSTAL ALIGNING AGENT CONTAINING POLYIMIDE PRECURSOR HAVING THERMALLY-LEAVING GROUP AND/OR POLYIMIDE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-09-15 | — | — | US | disclosed |
| US-20160244673-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-08-25 | — | — | US | disclosed |
| US-9303176-B2 | Hot melt ink composition, method for preparing a hot melt ink composition and use of a hot melt ink composition | OCE-TECHNOLOGIES B.V. (NL) | 2016-04-05 | — | — | US | disclosed |
| CN-101878309-B | Malonate decarboxylases for industrial applications | BASF SE (DE) | 2016-01-13 | — | — | CN | disclosed |
| US-20150124030-A1 | HOT MELT INK COMPOSITION, METHOD FOR PREPARING A HOT MELT INK COMPOSITION AND USE OF A HOT MELT INK COMPOSITION | OCE-TECHNOLOGIES B.V. (NL) | 2015-05-07 | — | — | US | disclosed |
| US-8901353-B2 | Polyimide precursor, polyimide, and liquid crystal aligning agent | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-12-02 | — | — | US | disclosed |
| US-8859803-B2 | Process for production of ketomalonic acid compounds or hydrates thereof | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 2014-10-14 | — | — | US | disclosed |
| US-8829153-B2 | Polyimide precursor composition containing polyamic acid alkyl ester | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-09-09 | — | — | US | disclosed |
| EP-2447243-A1 | PROCESS FOR PRODUCTION OF KETOMALONIC ACID COMPOUNDS OR HYDRATES THEREOF | Ihara Chemical Industry Co., Ltd. (JP) | 2012-05-02 | — | — | EP | disclosed |
| US-20120101236-A1 | POLYIMIDE PRECURSOR COMPOSITION CONTAINING POLYAMIC ACID ALKYL ESTER | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-04-26 | — | — | US | disclosed |
| US-20120088888-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, AND LIQUID CRYSTAL ALIGNING AGENT | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-04-12 | — | — | US | disclosed |
| US-20120088888-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, AND LIQUID CRYSTAL ALIGNING AGENT | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-04-12 | — | — | US | disclosed |
| US-20120004443-A1 | PROCESS FOR PRODUCTION OF KETOMALONIC ACID COMPOUNDS OR HYDRATES THEREOF | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 2012-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120004443-A1 | PROCESS FOR PRODUCTION OF KETOMALONIC ACID COMPOUNDS OR HYDRATES THEREOF | ME1, CA6, ME3 | LMNA 4430/4885GAA 240/4885KMT2A 683/4885 |
| US-20120088888-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, AND LIQUID CRYSTAL ALIGNING AGENT | PUF60, F13A1, F12 | LMNA 329/4885GAA 4561/4885KMT2A 380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.